https://www.selleckchem.com/pr....oducts/tertiapin-q.h
8 m during the 6MWT was set as the threshold for predicting clinical decompensation with 64% sensitivity and 82% specificity. Kaplan-Meier curve analysis revealed that patients who covered a distance of 401.8 m during the test had a decompensation-free outcome rate of 30% as compared to the rate of 75% of those who walked 401.8 m (p0.001). The 6MWT was a significant predictor of clinical decompensation in patients with cirrhosis. A cutoff of 401.8 m was related to an increased risk of clinical decompensation in cirrhot